| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/25/2002 | CA2432730A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | CA2431919A1 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 07/25/2002 | CA2431212A1 Immunogenic proteoliposomes, and uses thereof |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/25/2002 | CA2430589A1 Helper virus-free herpes virus amplicon particles and uses thereof |
| 07/25/2002 | CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | CA2426751A1 Plant transcription factors |
| 07/25/2002 | CA2406342A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/24/2002 | EP1225231A1 Environmental stress resistance gene |
| 07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
| 07/24/2002 | EP1225225A2 Osteogenic devices |
| 07/24/2002 | EP1225224A1 Shear stress-response dna |
| 07/24/2002 | EP1225222A1 Novel tumor suppressor gene |
| 07/24/2002 | EP1225184A1 Human antithrombin variants |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1225182A2 Human phospholipid transporter |
| 07/24/2002 | EP1225181A1 Protein expression and structure resolution using specific fusion vectors |
| 07/24/2002 | EP1224943A1 Fibronectin as a tumor marker detected by phage antibodies |
| 07/24/2002 | EP1224862A1 Model animal of mesangial cell proliferative nephritis |
| 07/24/2002 | EP1224473A2 Method for the determination autoantibodies raised against tsh receptors |
| 07/24/2002 | EP1224471A2 Dpi-6, a therapeutic biomarker in neurological disorders |
| 07/24/2002 | EP1224470A2 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 07/24/2002 | EP1224333A2 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 07/24/2002 | EP1224312A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 07/24/2002 | EP1224311A1 Recombinant, replication defective celo virus and celo virus dna |
| 07/24/2002 | EP1224303A2 Tms1 compositions and methods of use |
| 07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 07/24/2002 | EP1224301A2 Methods and compositions for targeting a cell |
| 07/24/2002 | EP1224297A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/24/2002 | EP1224291A1 Multiple sclerosis-related superantigen |
| 07/24/2002 | EP1224290A1 Disulfide conjugated cell toxins and methods of making and using them |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224287A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2 |
| 07/24/2002 | EP1224286A2 Gene mining system and method |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224284A1 Gene upregulated in cancers of the prostate |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224275A2 Molecules for diagnostics and therapeutics |
| 07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
| 07/24/2002 | EP1224271A1 Expression of recombinant mature lysostaphin |
| 07/24/2002 | EP1224265A1 Novel human potassium channel subunit |
| 07/24/2002 | EP1224261A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 07/24/2002 | EP1224223A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 07/24/2002 | EP1224222A2 Chemokine receptor |
| 07/24/2002 | EP1224221A1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224219A1 Beta-defensins |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224217A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 07/24/2002 | EP1224216A1 Mage-a1 peptides presented by hla class ii molecules |
| 07/24/2002 | EP1224215A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 07/24/2002 | EP1224214A1 Redox reversible hcv proteins with native-like conformation |
| 07/24/2002 | EP1224213A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224208A1 Human inwardly rectifying potassium channel subunit |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224199A1 Transgenic mice containing trp gene disruptions |
| 07/24/2002 | EP1223977A2 Modified plant viruses and methods of use thereof |
| 07/24/2002 | EP1223970A1 Short segments of dap-kinase |
| 07/24/2002 | EP1223968A2 Use of urodilatin for treating chronic kidney failure with residual kidney functions |
| 07/24/2002 | EP1223967A1 Fc GAMMA RIA |
| 07/24/2002 | EP1223964A1 April receptor (bcma) and uses thereof |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223958A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/24/2002 | EP1223953A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP1223802A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 07/24/2002 | EP1119367A4 Method of using fetuin to induce apoptosis in cancer cells |
| 07/24/2002 | EP1084132B1 Redox reversible imidazole-osmium complex conjugates |
| 07/24/2002 | EP0988045A4 Peptide nucleic acid monomers and oligomers |
| 07/24/2002 | EP0938679B1 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 07/24/2002 | EP0836485B1 Cascade polymer complexes |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0826001B1 Acellular pertussis vaccines and methods of preparation thereof |
| 07/24/2002 | EP0821593B1 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
| 07/24/2002 | EP0800579B1 Combination gene delivery vehicles |
| 07/24/2002 | EP0753577B1 Cell-surface polypeptide gene |
| 07/24/2002 | EP0733643B1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 07/24/2002 | EP0693941B1 Radiolabeled compounds for thrombus imaging |
| 07/24/2002 | EP0684835B1 Ligand antagonists for treatment of breast cancer |
| 07/24/2002 | EP0664832B1 Remyelination using neural stem cells |
| 07/24/2002 | EP0621285B1 Novel megakaryocyte potentiator |
| 07/24/2002 | EP0579640B1 Glial mitogenic factors, their preparation and use |
| 07/24/2002 | CN1360678A Early detection of flaviviruses using NS1 glycoprotein |
| 07/24/2002 | CN1360638A Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 07/24/2002 | CN1360636A Modified human granulocyte-colony stimulating factor and process for producing same |
| 07/24/2002 | CN1360632A Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| 07/24/2002 | CN1360631A Methods and compositions for preventing formation of aberrant RNA during transcription of plasmid sequence |
| 07/24/2002 | CN1360595A Immunogenic peptides derived from MAGE and use thereof |
| 07/24/2002 | CN1360594A Attenuated microorganisms for treatment of infection |
| 07/24/2002 | CN1360029A Polypeptide-human peroxidase protein 9.90 and polynucleotide for coding it |
| 07/24/2002 | CN1360022A Recombinant human epidermal growth factor and its preparing process and medicinal composition |
| 07/24/2002 | CN1359955A Polypeptide-human plexin 2 protein 56.11 and polynucleotide for coding it |
| 07/24/2002 | CN1359954A Polypeptide-human macroprotein 78 and polynucleotide for coding it |
| 07/24/2002 | CN1359953A Polypeptide-human cysteine switch 11.22 and polynucleotide for coding it |
| 07/24/2002 | CN1359952A Polypeptide-human macroprotein 65.12 and polynucleotide for coding it |
| 07/24/2002 | CN1359951A Polypeptide-human macroprotein 1128-85.69 and polynucleotide for coding it |
| 07/24/2002 | CN1359950A Polypeptide-chromatin collecting factor 1 subunit 18.26 and polynucleotide for coding it |